The IL-17A and VEGF loop can also induce TGF-β expression by immunosuppressive and tumor cells, stimulating VEGF receptors on endothelial cells, angiogenesis, tumor growth, and metastasis [44–46]. The gene discussed is IL17A; the disease is neoplasm.